Search Results for: RNF41

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
UBE2K ubiquitin conjugating enzyme E2 K
  • Synthesis of active ubiquitin: roles of E1 and E2 enzymes
  • Negative regulators of DDX58/IFIH1 signaling
  • Antigen processing: Ubiquitination & Proteasome degradation
UBE2U ubiquitin conjugating enzyme E2 U
  • Antigen processing: Ubiquitination & Proteasome degradation
UBE2Z ubiquitin conjugating enzyme E2 Z
  • Synthesis of active ubiquitin: roles of E1 and E2 enzymes
  • Antigen processing: Ubiquitination & Proteasome degradation
USP8 ubiquitin specific peptidase 8
  • Downregulation of ERBB2:ERBB3 signaling
  • Regulation of FZD by ubiquitination
  • Ub-specific processing proteases
  • Negative regulation of MET activity
ZAP70 zeta chain of T cell receptor associated protein kinase 70
  • Translocation of ZAP-70 to Immunological synapse
  • Generation of second messenger molecules
  • RHOH GTPase cycle
  • Nuclear events stimulated by ALK signaling in cancer
  • Staurosporine
  • Fostamatinib
  • Combined immunodeficiencies (CIDs), including the following nine diseases: X-linked hyper IgM syndrome; CD40 deficiency hyper IgM syndrome; Purine nucleoside phosphorylase (PNP) deficiency; Omenn syndrome; MHC deficiency (HLA-class I); MHC deficiency (HLA-class II); Zap-70 deficiency; p56 Lck deficiency; CD8 deficiency

Page 3 out of 3 pages